BMGL | tickerfilter.com

Fundamental analysis

25%

Profitability 18%

Dept financing 0%

Liquidity 0%

Performance 45%

Performance

5 Days

-1.78%

1 Month

-4.84%

3 Months

-35.86%

6 Months

-69.74%

1 Year

-85.57%

2 Year

-85.57%

Key data

Stock price

$0.59

P/E Ratio

N/A

DAY RANGE

$0.57 - $0.59

EPS

N/A

52 WEEK RANGE

$0.49 - $9.40

52 WEEK CHANGE

-$85.57

MARKET CAP

0.000

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$9,106

AVERAGE 30 VOLUME

$30,902

Company detail

CEO: Raymond Wai Man Cheung
Region: US
Website: baselmedical.com
Employees: 36
IPO year: 2025

Issue type:
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

Basel Medical transcends the role of a conventional healthcare provider. We strive for excellence in medical services and aim to serve as a beacon of hope for patients across Singapore and Southeast Asia. Our principal executive offices are located in Singapore.

BMGL - Basel Medical Group Ltd